Lantheus Holdings (LNTH) Other Accumulated Expenses (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Other Accumulated Expenses of $23.4 million for Q1 2026, up 79.11% year-over-year from $13.0 million in Q1 2025, and up 59.11% quarter-over-quarter from $14.7 million in Q4 2025.
Lantheus Holdings (LNTH) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Other Accumulated Expenses for 13 consecutive years, with $23.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 79.11% year-over-year to $23.4 million; the TTM figure through Mar 2026 stood at $23.4 million (up 79.11% YoY), while the FY2025 annual figure was $14.7 million, up 41.28% from the prior year.
- Other Accumulated Expenses climbed to $23.4 million in Q1 2026 per LNTH's latest filing, from $14.7 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $54.7 million in Q1 2024 and bottomed at $7.5 million in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $19.4 million across 5 years, with a median of $14.7 million in 2025.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 572.0% — and 2025, when it sank 76.14%.
- Lantheus Holdings' Other Accumulated Expenses stood at $25.5 million in 2022, then slumped by 53.36% to $11.9 million in 2023, then fell by 12.67% to $10.4 million in 2024, then jumped by 41.28% to $14.7 million in 2025, then jumped by 59.11% to $23.4 million in 2026.
- Business Quant data shows LNTH's Other Accumulated Expenses at $23.4 million in Q1 2026, $14.7 million in Q4 2025, and $20.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.70 Mn |
| Mar 31, 2026 | 23.37 Mn |
| Dec 31, 2025 | 14.69 Mn |
| Sep 30, 2025 | 20.93 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Mar 31, 2025 | 13.05 Mn |
| Dec 31, 2024 | 10.40 Mn |
| Sep 30, 2024 | 14.83 Mn |
| Jun 30, 2024 | 16.80 Mn |
| Mar 31, 2024 | 54.69 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | 22.56 Mn |
| Jun 30, 2023 | 11.16 Mn |
| Mar 31, 2023 | 50.38 Mn |
| Dec 31, 2022 | 25.53 Mn |
| Sep 30, 2022 | 11.14 Mn |
| Jun 30, 2022 | 11.01 Mn |
| Mar 31, 2022 | 7.50 Mn |
| Dec 31, 2021 | 5.35 Mn |
| Dec 31, 2020 | 6.13 Mn |